{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:07:37Z","timestamp":1777554457375,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatitis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1097\/der.0000000000000616","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T17:44:22Z","timestamp":1591206262000},"page":"15-18","source":"Crossref","is-referenced-by-count":9,"title":["T Helper 2 Inhibitors in Allergic Contact Dermatitis"],"prefix":"10.1177","volume":"32","author":[{"given":"Catherine M.","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Krase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"4","key":"bib3-20210818","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/DER.0000000000000391","article-title":"Chemokine signaling in allergic contact dermatitis: toward targeted therapies","volume":"29","year":"2018","journal-title":"Dermatitis"},{"key":"bib4-20210818","article-title":"Patch test practice patterns of members of the American Contact Dermatitis Society","year":"2019","journal-title":"Dermatitis"},{"issue":"2","key":"bib5-20210818","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjd.15239","article-title":"British Association of Dermatologists' guidelines for the management of contact dermatitis 2017","volume":"176","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"bib6-20210818","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/DER.0000000000000346","article-title":"Positive patch test reaction in a patient taking dupilumab","volume":"29","year":"2018","journal-title":"Dermatitis"},{"issue":"3","key":"bib7-20210818","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/DER.0000000000000357","article-title":"Patch testing in a patient on dupilumab","volume":"29","year":"2018","journal-title":"Dermatitis"},{"issue":"5","key":"bib8-20210818","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/DER.0000000000000409","article-title":"Effective use of dupilumab in managing systemic allergic contact dermatitis","volume":"29","year":"2018","journal-title":"Dermatitis"},{"issue":"6","key":"bib9-20210818","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DER.0000000000000414","article-title":"Dupilumab as a treatment for allergic contact dermatitis","volume":"29","year":"2018","journal-title":"Dermatitis"},{"issue":"9","key":"bib10-20210818","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jdcr.2018.08.027","article-title":"The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy","volume":"4","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"1","key":"bib11-20210818","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jamadermatol.2018.4098","article-title":"Patch testing and allergen-specific inhibition in a patient taking dupilumab","volume":"155","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"bib12-20210818","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jdcr.2019.01.023","article-title":"Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab","volume":"5","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"1","key":"bib13-20210818","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaad.2019.03.020","article-title":"Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis","volume":"81","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"bib14-20210818","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"bib15-20210818","first-page":"132","article-title":"The impact of dupilumab on patch testing and the prevalence of co-morbid ACD in recalcitrant atopic dermatitis: a retrospective chart review","volume":"82","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DER.0000000000000616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:29Z","timestamp":1777399529000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000616","relation":{},"ISSN":["2162-5220","1710-3568"],"issn-type":[{"value":"2162-5220","type":"electronic"},{"value":"1710-3568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,3]]}}}